KNOTUS Co.Ltd (278650) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Based on the latest financial reports, KNOTUS Co.Ltd (278650) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.34 Billion ≈ $-6.33 Million USD) by net assets (₩112.17 Billion ≈ $76.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 278650 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

KNOTUS Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how KNOTUS Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

KNOTUS Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of KNOTUS Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HIL Limited
NSE:HIL
0.049x
Premier Marketing Public Company Limited
BK:PM
0.134x
Melar Acquisition Corp. I Unit
NASDAQ:MACIU
-0.001x
Sam Young Chem
KO:003720
0.149x
Zeng Hsing Industrial Co Ltd
TW:1558
0.031x
CVW CleanTech Inc
V:CVW
-0.006x
WEST RED LAKE GOLD MINES
F:UJ0
0.167x
Owens & Minor Inc
NYSE:OMI
0.402x

Annual Cash Flow Conversion Efficiency for KNOTUS Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of KNOTUS Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of KNOTUS Co.Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩111.87 Billion
≈ $75.82 Million
₩-11.67 Billion
≈ $-7.91 Million
-0.104x -308.10%
2023-12-31 ₩103.57 Billion
≈ $70.19 Million
₩5.19 Billion
≈ $3.52 Million
0.050x -45.64%
2022-12-31 ₩70.28 Billion
≈ $47.63 Million
₩6.48 Billion
≈ $4.39 Million
0.092x -29.62%
2021-12-31 ₩64.59 Billion
≈ $43.77 Million
₩8.46 Billion
≈ $5.74 Million
0.131x -38.68%
2020-12-31 ₩53.64 Billion
≈ $36.35 Million
₩11.46 Billion
≈ $7.77 Million
0.214x +72.64%
2019-12-31 ₩41.86 Billion
≈ $28.37 Million
₩5.18 Billion
≈ $3.51 Million
0.124x -50.63%
2018-12-31 ₩20.67 Billion
≈ $14.01 Million
₩5.18 Billion
≈ $3.51 Million
0.251x -22.38%
2017-12-31 ₩16.04 Billion
≈ $10.87 Million
₩5.18 Billion
≈ $3.51 Million
0.323x -13.89%
2016-12-31 ₩8.36 Billion
≈ $5.66 Million
₩3.13 Billion
≈ $2.12 Million
0.375x --

About KNOTUS Co.Ltd

KQ:278650 Korea Biotechnology
Market Cap
$186.04 Million
₩274.53 Billion KRW
Market Cap Rank
#16915 Global
#654 in Korea
Share Price
₩3250.00
Change (1 day)
-5.39%
52-Week Range
₩1099.00 - ₩4785.00
All Time High
₩36886.01
About

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more